Trial Site Detail

 

Drug:
Imatinib + Regorafenib
Trial:
A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) (ALT GIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

Dept of Oncology, Haukeland University Hospital

     
Bergen , N-5021
Norway

 

Principal Investigator:
Contact:
Activation Status of this Site:
Active
Notes about this Site:
Dept of Oncology, Haukeland University Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.